Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Materialise NV (MTLS)
NASDAQ:MTLS
Earnings Data
Report Date
Apr 24, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.04Last Year’s EPS
0.06Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 20, 2025
|% Change Since: -35.36%
|Next Earnings Date:Apr 24, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance with strong growth in the Medical segment and advancements in Manufacturing, contrasted by challenges in the Manufacturing segment and increased costs leading to a negative EBIT in Q4. The deferred revenue in Software indicates potential future growth, but current market conditions remain challenging.Company Guidance
During the Materialise Fourth Quarter 2024 Financial Results Conference Call, the company provided guidance for 2025, indicating anticipated revenues in the range of €270 million to €285 million and an adjusted EBIT between €6 million and €10 million. The company expects continued growth in its Medical and Software segments, despite the ongoing transition of Software to a cloud-based subscription model. However, the Manufacturing segment is expected to face challenges due to the persistent uncertain macroeconomic environment in Europe. In 2024, Materialise achieved a 4% revenue growth with over €267 million in revenue, maintaining its adjusted EBIT stable while navigating a difficult year marked by high interest rates and geopolitical tensions. The company also highlighted strategic achievements, such as the launch of the Mimics platform and the opening of a new aerospace competence center in Delft, which contributed to a 28% revenue growth in the aerospace segment. Additionally, the transition of Software to a subscription-based model saw recurring revenue from software maintenance and license sales increase by 19% in the fourth quarter.Record Growth in Medical Segment
Materialise Medical achieved a 14% revenue growth in Q4 2024 and a 15% growth for the full year, setting a quarterly revenue record. Medical Devices and Services saw growth in both direct and partner sales.
Advancements in Manufacturing
Materialise expanded its aerospace segment with a 28% revenue growth for the year and opened an aerospace competence center in Delft. Additionally, the company saw over 30% growth in Huge and Heavy parts production.
Strong Deferred Revenue in Software
Deferred revenue related to software licenses and maintenance increased by €5.9 million in Q4 2024, ending at €46.9 million.
---
MTLS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MTLS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 20, 2025 | $9.22 | $5.96 | -35.36% |
| Oct 24, 2024 | $5.09 | $6.02 | +18.27% |
| Jul 31, 2024 | $5.65 | $6.50 | +15.04% |
| Apr 25, 2024 | $5.27 | $5.08 | -3.61% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Materialise NV (MTLS) report earnings?
Materialise NV (MTLS) is schdueled to report earning on Apr 24, 2025, TBA Not Confirmed.
What is Materialise NV (MTLS) earnings time?
Materialise NV (MTLS) earnings time is at Apr 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MTLS EPS forecast?
MTLS EPS forecast for the fiscal quarter 2025 (Q1) is -0.04.
---